Skip to content
Tenfell
Awarded contract
Published 19 Apr 2021

National Microbiology Framework - Lot 4 Clinical Laboratory Diagnostic Testing Services

Public Health England · United Kingdom

Key facts

Awarded
23 Feb 2021
Contract starts
22 Mar 2021
Contract ends
21 Mar 2023
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 50 suppliers

SupplierValue
Liverpool University Hospitals NHS Foundation Trust—
Queen Mary University of London—
NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST—
Imperial College Projects Limited—
Sheffield Teaching Hospitals NHS Foundation Trust—
Randox Laboratories—
The Newcastle upon Tyne Hospitals NHS Foundation Trust—
Source Bioscience UK Limited—
University Hospitals of Leicester NHS Trust—
UNIVERSITY OF GLASGOW—
HSL Pathology LLP—
Northgate Public Services (UK) Limited—
PerkinElmer LAS (UK) Limited—
King's College, London—
South West London Pathology—
Accora Limited—
MEDICINES DISCOVERY CATAPULT SERVICES LIMITED—
University Hospitals Birmingham NHS Foundation Trust—
Eurofins Biomnis—
UK Biocentre Limited—
YOURGENE HEALTH UK LTD—
Unilabs—
PURA DIAGNOSTICS LIMITED—
Mornington 2000 LLP—
North Bristol NHS Trust—
COVANCE LABORATORIES LIMITED—
BGI Genomics UK Co Ltd—
Honeyman Group Limited—
PRENETICS EMEA—
Alphabiolaboratories Analytical Limited—
Covid Testing Network—
Thriva Limited—
Immensa Health Clinic Ltd—
ProMake Ltd—
Ecolog International UK Limited—
Crown Laboratories Limited—
Acculabs Diagnostic UK Limited—
Berkshire and Surrey Pathology Services—
BioClavis Limited—
Cambridge Clinical Laboratories Ltd—
Excalibur Diagnostics Limited—
Hexa Health Ltd—
Latus Health Ltd—
LinksBio Limited—
Luxe Life Care Ltd—
Medical Diagnosis Ltd—
MOTOPARA Foundation, Inc.—
PAJS Services Limited—
Pure Genetic Medical Ltd—
Secret Compass—

Description

Lot 4 - Clinical Laboratory Diagnostic Testing Services is intended to enable access to Clinical Laboratory Diagnostic Testing Services using extant techniques and allow for the addition of new techniques or existing techniques utilised in a new manner in the future. The Lot is to ensure that there are consistent and affordable provision of high quality, safe and compliant testing services which should be delivered efficiently and effectively to support wider clinical services.

Please note that this Award Notice is for Lot 4, however the Framework Agreement encompasses the following four lots: - Lot 1: Diagnostic Goods and Services - Lot 2: Research and Development Goods and Services - Lot 3: Manufacturing, Product Development and Commercialisation - Lot 4: Clinical Laboratory Diagnostic Testing Services

Additional information: The term of the framework is for an initial 2 years with options to extend by up to a further 2 years.

The value attributed to this Lot is an approximate estimate only, the actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements.

The scope of this Framework Agreement covers Goods and Services that are subject to rapid and frequent improvements, advancements and new scientific and technical developments. Therefore, to keep this Framework Agreement in line with the latest market and scientific developments so as to ensure that patients and other end users have ongoing access to state of the art diagnostics for the duration of this Framework Agreement successful Suppliers will be able to propose new and/or updated Goods and/or Services to be added to a Supplier's range under the Framework Agreement if one or more of the following circumstances apply:

- Where the proposed updated Goods or Services fall within the general scope of this procurement as set out as part of this OJEU Contract Notice (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the description sections of this Contract Notice); - Where the proposed new Goods or Services fall within the broad categories of Goods or Services covered by this Framework Agreement (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice), but are new to the market. For the avoidance of doubt, for the purposes of any testing services, this will allow Suppliers to offer new types of tests, new test kits, related new equipment / products, related new consumables and related new Services as and when they become available during the duration of the Framework Agreement provided they fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice); - Where the proposed new or updated Goods or Services reflect a product or service line extension (i.e. are new, modified or updated products or services in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement); or - Where the proposed new or updated Goods or Services reflect a range extension (i.e. are new, modified or updated products or services that reflect an expansion of the Supplier's range in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement).

Categories (CPV)

Similar open tenders

About Public Health England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.